CO
Coeptis Therapeutics Holdings, Inc.
COEPW · NASDAQ
$0.01 +0.00% (+$0.00)
Market Cap $64.7K
P/E Ratio -
Div. Yield -
ROE 123.49%
Bulios Fair Price
$0.01
3.8% downside
Current Price
$0.01
Undervalued Fair Value Overvalued
According to Bulios Fair Price, COEPW is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/S 0.05x
P/B 0.00x
P/E N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Gross margin 9.69%
Net margin 874.29%
FCF margin 631.16%
Quality
1 /100
Poor ROIC 118.59%
ROE 123.49%
Asset turnover 0.08x
Debt
80 /100
Low Debt/Equity 0.01x
Current ratio 4.16x
Net debt/EBITDA 0.48x
Stability
1 /100
Unstable Beta 2.42x
EPS volatility 1,828.74%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about COEPW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David Mehalick
Employees
4
Headquarters
Wexford